key: cord-0723583-qqgso9oo
authors: Péré, Hélène; Podglajen, Isabelle; Wack, Maxime; Flamarion, Edouard; Mirault, Tristan; Goudot, Guillaume; Hauw-Berlemont, Caroline; Le, Laetitia; Caudron, Eric; Carrabin, Sophie; Rodary, Julien; Ribeyre, Tatiana; Bélec, Laurent; Veyer, David
title: Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab Shortage
date: 2020-05-26
journal: J Clin Microbiol
DOI: 10.1128/jcm.00721-20
sha: 5753edb92d9d125c874495efda84c98b9c7e4d30
doc_id: 723583
cord_uid: qqgso9oo

Nasopharyngeal swab is the reference sampling method to detect SARS CoV2, as recommended by world Health Organization (WHO) (1).….

KEYWORDS COVID-19, nasal swab, nasopharyngeal swab, RT-PCR, SARS-CoV-2, molecular diagnosis N asopharyngeal swab is the reference sampling method to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as recommended by the World Health Organization (WHO) (1) . However, nasal specimens may have a slightly lower sensitivity than nasopharyngeal specimens (2, 3) . We herein validated an alternative procedure to collect nasal secretions with a swab routinely used in medical bacteriology for which there is no risk of supply disruption in order to perform the molecular diagnosis of SARS-CoV-2 infection.

Patients who were suspected of having coronavirus disease 2019 (COVID-19) attending the Hôpital Européen Georges Pompidou, Paris, France, were for their own care according to medical decision prospectively included and subjected to SARS-CoV-2 molecular testing using nasopharyngeal swab (Xpert nasopharyngeal sample collection kit; Cepheid, Sunnyvale, CA, USA) and nasal swab (Copan Transystem; Copan, Brescia, Italy).

Nasal and nasopharyngeal swabs were inserted in the nostril until they hit an obstacle (the inferior concha and the back of the nasopharyngeal cavity, respectively), rotated five times, and removed. The test was conducted in only one nostril per patient. After sampling, the nasopharyngeal swab was inserted into a vial containing 3 ml of virus transport medium (Xpert viral transport medium; Cepheid), and the nasal swab was placed in a 15-ml tube containing 3 ml of saline solution (0.9% NaCl). SARS CoV-2 was detected using Allplex 2019-nCoV assay (Seegene, Seoul, Korea).

A total of 44 patients were prospectively included up to the end of March 2020. Their median age was 63.0 years, ranging from 18 to 94 years. There were 23 (52.3%) male and 21 female patients. A total of 37 (84.1%) patients showed laboratoryconfirmed SARS-CoV-2 infection using nasopharyngeal swab, with 7 patients giving negative results (15.9%) ( Table 1) .

Out of 37 patients that were positive for SARS-CoV-2 by nasopharyngeal swab testing, 33 also tested positive by nasal sampling. All SARS-CoV-2-negative patients with nasopharyngeal swabs (n ϭ 7) gave negative test results using nasal swabs (Table 1) .

By reference to nasopharyngeal sampling, the detection of SARS-CoV-2 by nasal sampling provided 7 (15.9%) true SARS-CoV-2-negative specimens, 4 (9.1%) falsenegative specimens, and 33 (75.0%) true SARS-CoV-2-positive specimens. Thus, the sensitivity of SARS-CoV-2 RNA detection by multiplex real-time PCR from nasal secretions was 89.2% (95% confidence interval [95% CI], 75.3 to 95.7), and its specificity was 100.0% (95% CI, 94.6 to 100.0). The index was 0.72, indicating substantial concordance between nasal and nasopharyngeal swabbing to detect SARS-CoV-2 according to Landlis and Koch rank. The Youden J index was calculated at 89.2%, demonstrating good efficiency to detect SARS-CoV-2 RNA.

Threshold cycle (C T ) (mean Ϯ standard deviation [SD]) values for E (envelope), RdRP (RNA-dependent RNA polymerase) and N (nucleocapsid) genes by nasopharyngeal (23.9 Ϯ 4.9 for E, 26.3 Ϯ 5.5 for RdRP, and 28.9 Ϯ 6.1 for N) and nasal (22.3 Ϯ 5.2 for E, 24.6 Ϯ 5.9 for RdRP, and 27.9 Ϯ 6.1 for N) swab testing were similar. Differences in C T values for the E, RdRP, and N genes were not statistically significant (P ϭ 0.56, 0.84, and 0.57, respectively).

We herein report that the molecular detection of SARS-CoV-2 using nasal swab specimens was nearly equivalent to the detection using nasopharyngeal swab considered the gold standard. SARS-CoV-2 detection from nasal samples showed high sensitivity and specificity. Agreement and accuracy of test results using nasal sampling by reference to gold standard nasopharyngeal sampling were estimated as substantial and good, respectively. Taken together, these observations demonstrate that nasal sampling could be used to screen SARS-CoV-2 in times of nasopharyngeal swab shortage. 

Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. WHO/COVID-19/laboratory/2020.5. World Health Organization

Comparing nose-throat swabs and nasopharyngeal aspirates collected from children with symptoms for respiratory virus identification using real-time polymerase chain reaction

Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction

We thank the patients and the nurses and clinical staff who are providing care for the patients.